Yeah yeah yeah blah blah blah
more than 12 months on from first telling the market they’d start testing their compound library in Covid , in between cups of tea they think they have something to take into mice. Quick open the champagne!
oh and nice little bit in there to hook the more naive sections of the market with the reference to same as or a maybe bit better than remdesivir. In cell cultures. I repeat- in cell cultures. Truth is they have nothing and for a company to be tinkering in this field for 20 years and produce nothing but somehow remain in operation is an utter disgrace.
I ask again: what is the point of this company?
Ann: Lead Series for SARS-COV-2 Program, page-69
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
